PET Study in Healthy Subjects to Determine the Relationship Between Plasma Concentration and Brain Target Occupancy of ASN51

Conditions: Alzheimer Disease Interventions: Drug: ASN51 Sponsors: Asceneuron S.A. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials